Achieve Life Sciences (ACHV) Operating Income (2010 - 2012)

Achieve Life Sciences' (ACHV) quarterly Operating Income came in at $8.3 million in Q3 2012, up 102.34% YoY from $4.1 million in Q4 2011, and up 39.47% on a QoQ basis from $5.9 million in Q2 2012.

Achieve Life Sciences (ACHV) Operating Income (2010 - 2012) Analysis & Trends

Achieve Life Sciences (ACHV) has 3 years of Operating Income data on file, last reported at $8.3 million in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 493.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -505.13 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 325.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -3,158.03
7 Royalty Pharma 33.72 Bn 35.84 Bn - 133.12 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 231.44 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -1.55 Mn
10 Achieve Life Sciences 330.88 Mn 330.88 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2012 8.29 Mn
Jun 30, 2012 5.94 Mn
Mar 31, 2012 -5.50 Mn
Sep 30, 2011 4.10 Mn
Jun 30, 2011 4.99 Mn
Mar 31, 2011 -5.23 Mn
Sep 30, 2010 -6.95 Mn
Jun 30, 2010 -2.85 Mn